“What recent assessment he has made of the implications for his policies of the economic growth rate.”
Asked by
Chris Elmore
Answering Minister
the Chancellor of the Exchequer
Answer from Hansard
The Minister for Care (Stephen Kinnock)
I thank my hon. Friend for that question and welcome him to his place. This issue is personal for me, and I am sure it is for many others across this House. A number of potential new disease-modifying drugs for Alzheimer’s are in the pipeline, including lecanemab and donanemab. We are committed to ensuring that clinically effective and cost-effective medicines reach patients in a timely and safe way. The National Institute for Health and Care Excellence is appraising lecanemab and donanemab to determine whether they will be made available in the NHS.